211 related articles for article (PubMed ID: 30239071)
21. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous manifestations of chronic arsenicism: review of seventeen cases.
Wong SS; Tan KC; Goh CL
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):179-85. PubMed ID: 9486671
[TBL] [Abstract][Full Text] [Related]
23. Red light laser photodynamic therapy of Bowen's disease.
Parlette EC
J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
[No Abstract] [Full Text] [Related]
24. Successful Treatment for Extensive Bowen's Disease using Daylight-mediated Photodynamic Therapy.
Safar R; Alkhars A; Tallegas M; Korsaga-Some N; Machet L
Acta Derm Venereol; 2019 Jun; 99(7):701-702. PubMed ID: 30868171
[No Abstract] [Full Text] [Related]
25. Dye laser photodynamic therapy for Bowen's disease in a patient with epidermodysplasia verruciformis.
Sunohara M; Ozawa T; Morimoto K; Harada T; Ishii M; Fukai K
Osaka City Med J; 2012 Dec; 58(2):77-82. PubMed ID: 23610850
[TBL] [Abstract][Full Text] [Related]
26. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.
Varma S; Wilson H; Kurwa HA; Gambles B; Charman C; Pearse AD; Taylor D; Anstey AV
Br J Dermatol; 2001 Mar; 144(3):567-74. PubMed ID: 11260016
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic options for Bowen's disease.
Moreno G; Chia AL; Lim A; Shumack S
Australas J Dermatol; 2007 Feb; 48(1):1-8; quiz 9-10. PubMed ID: 17222293
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
29. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
Torchia D; Massi D; Caproni M; Fabbri P
Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
[No Abstract] [Full Text] [Related]
30. Successful treatment for multiple Bowen's disease using photodynamic therapy: A case report.
Wu MF; Lv T; Wang HW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101783. PubMed ID: 32330610
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study.
Kacerovská D; Pizinger K; Majer F; Smíd F
Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
33. Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure?
Ohnishi Y; Murakami S; Ohtsuka H; Miyauchi S; Shinmori H; Hashimoto K
J Dermatol; 1997 May; 24(5):310-6. PubMed ID: 9198320
[TBL] [Abstract][Full Text] [Related]
34. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of extremely large Bowen's disease lesion by topical photodynamic therapy and imiquimod: Using optical coherence tomography to detect early recurrence loci and validate the cure.
Wang WE; Chang CH
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103201. PubMed ID: 36375799
[TBL] [Abstract][Full Text] [Related]
36. Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.
Hambly R; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Br J Dermatol; 2017 Sep; 177(3):e55-e57. PubMed ID: 28028807
[No Abstract] [Full Text] [Related]
37. [The value of photodynamic therapy in the treatment of Bowen's disease].
Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
Ann Dermatol Venereol; 2008 Dec; 135(12):822-7. PubMed ID: 19084691
[TBL] [Abstract][Full Text] [Related]
38. Arsenic keratosis and pigmentation accompanied by multiple Bowen's disease and genitourinary cancer in a psoriasis patient.
Park JY; Rim JH; Choe YB; Youn JI
J Dermatol; 2002 Jul; 29(7):446-51. PubMed ID: 12184646
[TBL] [Abstract][Full Text] [Related]
39. Multiple Bowen's disease associated with squamous cell carcinoma--a report of a case.
Ismail R; Cheng PS
J Dermatol; 1988 Feb; 15(1):65-7. PubMed ID: 2969012
[No Abstract] [Full Text] [Related]
40. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Cairnduff F; Stringer MR; Hudson EJ; Ash DV; Brown SB
Br J Cancer; 1994 Mar; 69(3):605-8. PubMed ID: 8123497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
